ASCO 2025 will feature the latest advancements in genitourinary cancer and melanoma treatment, focusing on the exciting developments in immunotherapy. Stay updated on the cutting-edge research and ...

The Rowena wildfire has destroyed 56 homes and 91 other buildings, including sheds, barns and shops in Wasco County, the ...

Cancer cases are on the rise in young people but misdiagnosis remains an issue, with everything from anxiety to menopause ...

ASCO discussant Krina Patel, MD, MSc, of the University of Texas MD Anderson Cancer Center in Houston, noted that "ciltacabtagene autoleucel is the first potential functional cure for patients ...

Immunotherapies like Opdivo, Tecentriq and Imfinzi were first approved eight to 10 years ago. Now, after marching up through metastatic treatment of various tumors, data at ASCO demonstrated how they ...

Leaders in oncology share why the American Society of Clinical Oncology (ASCO) meeting remains a top global gathering for breakthroughs, networking, and lifelong learning.

HealthDay News — For women with moderate-to-severe vasomotor symptoms associated with endocrine therapy for hormone receptor (HR)-positive breast cancer, elinzanetant, a neurokinin-targeted ...

(HealthDay News) — For adults with diabetes and obesity, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are associated with a reduced risk for obesity-related cancer compared with ...

The early-career researchers awarded with the prestigious Young Investigator Award (YIA) research grant from Conquer Cancer, the ASCO Foundation include 2024 hematology-oncology fellowship graduates ...